Ann Rhoads Buys Shares of QDEL
Ann Rhoads expanded her position in QDEL by acquiring 369 shares.
Key Points
- Ann Rhoads purchased 369 shares of QDEL on June 25, 2026, with the transaction not being planned.
- Shares of QDEL traded near $13.79 on Tuesday with active institutional interest from firms like BlackRock and FMR LLC.
- Analysts from Jefferies and Citigroup recently maintained or downgraded QDEL to hold ratings with varied price targets.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Ann Rhoads recently expanded her stake in QDEL by purchasing 369 shares on June 25, 2026. The transaction was not part of a planned trading program.
Other Institutional Activity in QDEL
BlackRock, Inc. grew its holdings by 107,409 shares, ending with 10,449,127 shares valued at about $171.7 million. FMR LLC increased its position significantly by 1,170,934 shares, bringing its total to 6,591,152 shares worth approximately $108.3 million, marking a 21.6% increase. T. Rowe Price Investment Management, Inc. reduced its stake by 6,202,133 shares, now holding 5,629,965 shares valued at $92.5 million, which is a decrease of 52.4%. Newtyn Management, LLC added 1,543,877 shares, resulting in a 51.2% increase, and Vanguard Portfolio Management LLC opened a new position with 4,031,768 shares valued at $66.2 million.
QuidelOrtho Corporation Stock Down 6.4%
Shares of QDEL traded near $13.79 on Tuesday. The stock has seen varied interest from institutional investors, as seen in recent activity. Analyst opinions also reflect a cautious stance, with recent ratings primarily being holds.
$QDEL stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at QuidelOrtho Corporation
On June 25, 2026, several insiders, including John Chiminski and Kenneth Widder, purchased shares of QDEL. John Chiminski acquired 1,109 shares, and Kenneth Widder bought 1,997 shares, among others, with all transactions occurring outside of planned trading programs.
Analysts Set New Price Targets
On May 7, 2026, Jefferies downgraded QDEL to a hold rating with a price target of $12.50. Citigroup maintained its hold rating on May 6, 2026, with a target of $13.00. Meanwhile, UBS maintained its hold rating on April 10, 2026, with a target of $17.00.
Bottom Line
Ann Rhoads' recent purchase of QDEL shares adds to a series of insider transactions that occurred on June 25, 2026. Institutional interest remains strong, with significant activity from major funds. Analyst ratings suggest a cautious approach, reflecting varied price targets and hold ratings. As always, these insider and institutional activities provide insights into market sentiment, but investors should remember that insider buying does not necessarily indicate future stock performance.
Get QuidelOrtho Corporation alerts
New 13F filings, insider trades, and analyst moves on $QDEL, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.